These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 19187433)

  • 1. Safety, immunogenicity and efficacy of peptide-pulsed cellular immunotherapy in macaques.
    De Rose R; Mason RD; Loh L; Peut V; Smith MZ; Fernandez CS; Alcantara S; Amarasena T; Reece J; Seddiki N; Kelleher AD; Zaunders J; Kent SJ
    J Med Primatol; 2008 Dec; 37 Suppl 2():69-78. PubMed ID: 19187433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of immunotherapy with peptide-pulsed blood in macaques.
    De Rose R; Fernandez CS; Loh L; Peut V; Mason RD; Alcantara S; Reece J; Kent SJ
    Virology; 2008 Sep; 378(2):201-4. PubMed ID: 18620724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pigtail macaque MHC class I allele Mane-A*10 presents an immundominant SIV Gag epitope: identification, tetramer development and implications of immune escape and reversion.
    Smith MZ; Fernandez CS; Chung A; Dale CJ; De Rose R; Lin J; Brooks AG; Krebs KC; Watkins DI; O'Connor DH; Davenport MP; Kent SJ
    J Med Primatol; 2005 Oct; 34(5-6):282-93. PubMed ID: 16128923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential patterns of immune escape at Tat-specific cytotoxic T cell epitopes in pigtail macaques.
    Mason RD; De Rose R; Kent SJ
    Virology; 2009 Jun; 388(2):315-23. PubMed ID: 19394064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substantial envelope-specific CD8 T-cell immunity fails to control SIV disease.
    Peut V; Kent SJ
    Virology; 2009 Feb; 384(1):21-7. PubMed ID: 19091370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivated simian immunodeficiency virus-pulsed autologous fresh blood cells as an immunotherapy strategy.
    Mason RD; Alcantara S; Peut V; Loh L; Lifson JD; De Rose R; Kent SJ
    J Virol; 2009 Feb; 83(3):1501-10. PubMed ID: 19019966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood.
    De Rose R; Fernandez CS; Smith MZ; Batten CJ; Alcântara S; Peut V; Rollman E; Loh L; Mason RD; Wilson K; Law MG; Handley AJ; Kent SJ
    PLoS Pathog; 2008 May; 4(5):e1000055. PubMed ID: 18451982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low pre-infection levels and loss of central memory CD4+ T cells may predict rapid progression in SIV-infected pigtail macaques.
    Mason RD; Rose RD; Seddiki N; Kelleher AD; Kent SJ
    Virology; 2008 Nov; 381(1):11-5. PubMed ID: 18835006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
    J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus 5- and 35-based immunotherapy enhances the strength but not breadth or quality of immunity during chronic SIV infection.
    Soloff AC; Liu X; Gao W; Day RD; Gambotto A; Barratt-Boyes SM
    Eur J Immunol; 2009 Sep; 39(9):2437-49. PubMed ID: 19670380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced cellular immunity in macaques following a novel peptide immunotherapy.
    Chea S; Dale CJ; De Rose R; Ramshaw IA; Kent SJ
    J Virol; 2005 Mar; 79(6):3748-57. PubMed ID: 15731268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo fitness costs of different Gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques.
    Loh L; Batten CJ; Petravic J; Davenport MP; Kent SJ
    J Virol; 2007 May; 81(10):5418-22. PubMed ID: 17344299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of recombinant Kunjin replicon SIV vaccines for protective efficacy in macaques.
    Kent SJ; De Rose R; Mokhonov VV; Mokhonova EI; Fernandez CS; Alcantara S; Rollman E; Mason RD; Loh L; Peut V; Reece JC; Wang XJ; Wilson KM; Suhrbier A; Khromykh A
    Virology; 2008 May; 374(2):528-34. PubMed ID: 18272194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural host genetic resistance to lentiviral CNS disease: a neuroprotective MHC class I allele in SIV-infected macaques.
    Mankowski JL; Queen SE; Fernandez CS; Tarwater PM; Karper JM; Adams RJ; Kent SJ
    PLoS One; 2008; 3(11):e3603. PubMed ID: 18978944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mhc class I haplotypes associated with survival time in simian immunodeficiency virus (SIV)-infected rhesus macaques.
    Sauermann U; Siddiqui R; Suh YS; Platzer M; Leuchte N; Meyer H; Mätz-Rensing K; Stoiber H; Nürnberg P; Hunsmann G; Stahl-Hennig C; Krawczak M
    Genes Immun; 2008 Jan; 9(1):69-80. PubMed ID: 18094710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal prior to systemic application of recombinant adenovirus boosting is more immunogenic than systemic application twice but confers similar protection against SIV-challenge in DNA vaccine-primed macaques.
    Schulte R; Suh YS; Sauermann U; Ochieng W; Sopper S; Kim KS; Ahn SS; Park KS; Stolte-Leeb N; Hunsmann G; Sung YC; Stahl-Hennig C
    Virology; 2009 Jan; 383(2):300-9. PubMed ID: 19027133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide-loaded dendritic cell based cytotoxic T-lymphocyte (CTL) vaccination strategy using peptides that span SIV Tat, Rev, and Env overlapping reading frames.
    Klase Z; Donio MJ; Blauvelt A; Marx PA; Jeang KT; Smith SM
    Retrovirology; 2006 Jan; 3():1. PubMed ID: 16398928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of SIV DNA vaccine-induced cellular immunity by targeting the 4-1BB costimulatory molecule.
    Calarota SA; Hokey DA; Dai A; Jure-Kunkel MN; Balimane P; Weiner DB
    Vaccine; 2008 Jun; 26(25):3121-34. PubMed ID: 18336959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection afforded by live attenuated SIV is associated with rapid killing kinetics of CTLs.
    Rollman E; Mason RD; Lin J; Brooks AG; Kent SJ
    J Med Primatol; 2008 Dec; 37 Suppl 2():24-32. PubMed ID: 19187428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance P receptor antagonist reverses intestinal pathophysiological alterations occurring in a novel ex-vivo model of Cryptosporidium parvum infection of intestinal tissues derived from SIV-infected macaques.
    Garza A; Lackner A; Aye P; D'Souza M; Martin P; Borda J; Tweardy DJ; Weinstock J; Griffiths J; Robinson P
    J Med Primatol; 2008 Jun; 37(3):109-15. PubMed ID: 18547256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.